Advertisement

COVID-19 Vaccine Trial Paused Due To Illness In Volunteer

The AstraZeneca/Oxford partnership is one of the vaccine development efforts that is furthest along. The company recently began a Phase 3 trial in the United States that aims to enroll 30,000 volunteers. (AP)
The AstraZeneca/Oxford partnership is one of the vaccine development efforts that is furthest along. The company recently began a Phase 3 trial in the United States that aims to enroll 30,000 volunteers. (AP)

Related:

Advertisement

More from WBUR

Listen Live
Close